Frederick J. Lynch - 24 Sep 2020 Form 3 Insider Report for H-CYTE, INC. (HCYT)

Role
10%+ Owner
Signature
/s/ Frederick J. Lynch
Issuer symbol
HCYT
Transactions as of
24 Sep 2020
Net transactions value
$0
Form type
3
Filing time
17 Feb 2022, 18:38:24 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCYT Series A Preferred Stock 24 Sep 2020 Common Stock 51,208,219 See Footnote F1, F2, F3
holding HCYT Stock Purchase Warrants 24 Sep 2020 Common Stock 26,208,219 $0.0140 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Redeemable at option of requisite number of holders in specified circumstances.
F2 Series A stock is convertible into common stock on a 1:1 basis.
F3 Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
F4 Not applicable.